Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention

Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention

The COVID-19 infection caused by the new SARS-CoV-2 virus has been linked to a broad spectrum of symptoms, from a mild cough to life-threatening pneumonia. As we learn more about this unusual COVID-19 epidemic, new issues are emerging and being reported daily. Mucormycosis, also known as zygomycosis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Syed Mohammed Basheeruddin Asdaq, Arya Rajan, Aswin Damodaran, Shivali R. Kamath, Krishnanjana S. Nair, Subin Mary Zachariah, Ram Kumar Sahu, Santosh Fattepur, Nagaraja Sreeharsha, Anroop Nair, Shery Jacob, Hussain A. Albahrani, Eman H. Alkhaldi, Yahya Mohzari, Ahmed A. Alrashed, Mohd. Imran
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID-19
mucormycosis
nanotechnology
antifungal
diabetes
diagnosis
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/fdd41567703c452e88a45bbee7c93556
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/fdd41567703c452e88a45bbee7c93556

Ejemplares similares